Chart of the Month: Too Big to Grow in the Spine Market?
Our chart of the month shows the projected top 10 largest players in spine after recent M&A deals in the market segment. Feb 28, 2023
Vericel’s MACI Primed for Growth
The company's MACI sales grew more than 18% for FY22 and greatly accelerated its path toward a new arthroscopic delivery method. Feb 28, 2023
Orthopedic Execs Talk Tech, M&A and Surgical Volumes
Ortho execs on enabling technology’s important role in implant sales, recent M&A deals that worked and improving surgical procedure volumes. Feb 27, 2023
Enovis Flourishes in First Year as Stand-Alone
Enovis reported 4Q22 orthopedic sales of $162.5 million, +10.4% compared to 4Q21. Including contributions from acquisitions, the company generated $599.4... Feb 27, 2023
Medtronic’s Arsenal of Technology Driving Growth
The company's reported orthopedic sales grew by low-single digits during the third quarter of its 2023 fiscal year. Feb 27, 2023
3 Market Trends in Joint Replacement
New technologies, increasing cementless adoption and volume-based procurement in China set the stage for a dynamic year in joint replacement. Feb 24, 2023
NuVasive’s Cervical and International Sales Drive 2022 Growth
The company exited 2022 with mid-single digit growth despite macro headwinds, driven by its C360 portfolio and international sales. Feb 24, 2023
Globus Crossed $1 Billion Threshold in 2022
The company exceeded $1 billion in annual sales for the first time in 2022, representing high-single digit growth compared to 2021. Feb 23, 2023
Smith+Nephew Exits 2022 With Improved Execution
The company exited 2022 with early momentum in its plan to revitalize its orthopedics franchise and improve execution. Feb 22, 2023
Making Sense of Globus Medical’s Deal for NuVasive
The company's pending acquisition of NuVasive is about increasing operational capacity and vertical integration. Feb 15, 2023
